FindTrial
Sign In

Occurrence and Risk Factors of Post-Radiotherapy Trismus in Oral Cavity Cancer Patients

A Prospective study to assess the occurrence and factors causing trismus in patients with oral Cavity cancers Post Radiotherapy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/105530
Enrollment
50
Registered
2026-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Intervention1: Nil: Nil

Sponsors

Sri Venkateshwara Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Histo-pathologically proven squamous cell carcinoma [SCC] of oral and oropharyngeal cancers 2.Age : 18 -70 years . 3.Patients with eastern cooperative oncology group [ECOG] performance status of 0-2 4.Stage I to IV B SCC of oral cavity cancers [American joint committee on cancer : 8th edition 5. Patients treated with surgery

Exclusion criteria

Exclusion criteria: 1.Cancer with distant metastasis. 2.Patient with ECOG performance status of 3-4. 3.Patients previously treated with radiotherapy to head & neck region. 4.Pregnant and lactating mothers.

Design outcomes

Primary

MeasureTime frame
To assess occurrence of trismus in oral cavityTimepoint: three months—

Secondary

MeasureTime frame
To assess contributing risk factors in development of trismusTimepoint: three months—

Countries

India

Contacts

Public ContactPriya Bowjenku

Sri Venkateshwara Institute of Medical Sciences

ravibalasubramanian@hotmail.com9849692950

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026